Login
Navigate Fool.com
Will DNDN beat
the market?

Dendreon Corp

NASDAQ: DNDN

Community Rating: 2 Stars: Unattractive

3.93 -0.02 (-0.51%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.90
Previous Close $3.95
Daily Range $3.86 - $3.98
52-Week Range $3.69 - $7.94
Market Cap $619.4M
P/E Ratio -1.63
Dividend (Yield) $0.00 (0.0%)
Volume 1,295,189
Average Daily Volume 4,868,041
Current FY EPS -$1.60

How do you think DNDN
will perform against the market?

Top DNDN Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 5, 2011

Wow. I haven't followed Dendreon closely since I predicted incorrectly that their repeat phase III trial of Provenge would fail. I maintained some skepticism about the commercial potential of Provenge … More

0 Replies Reply Report this Post
 

DarthMaul09 (< 20)
Submitted November 5, 2011

Medication formularies are more likely to contract as profit margins for insurance companies fall. Independent of how potentially beneficial a new drug may initially appear, there will be a slow acce … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Biotech Investing for Beginners

3 pointers to help make biotech investing for beginners a little less intimidating.

One Person's Trash Is Another Person's Treasure Portfolio

A year-long exercise intent on proving that value and contrarian investing can be incredibly successful.

2 Scenarios Where Buy and Hold Rarely Works

Historically, buy-and-hold investors will outperform over the long run, but it's not always as simple as it looks if you invest in these two types of companies.

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert

5 of Last Week's Biggest Losers

These five stocks posted double-digit declines this past week.

Dendreon: Picking Through the Carnage

First-quarter results for the prostate cancer drug maker were even uglier than anticipated.

A Fool Looks Back

There were a lot of things happening in the market this past week.

3 Horrendous Health-Care Stocks This Week

These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.

Friday's Top Upgrades (and Downgrades)

Analysts shift stance on Raytheon, Workday, and Dendreon.

Pre-Market Most Active for May 10, 2013 : DELL, DDD, APO, NOK, BAC, ING, NVS, PTIE, DNDN, NVDA, ERI

Pre-Market Most Active for May 10, 2013 : DELL, DDD, APO, NOK, BAC, ING, NVS, PTIE, DNDN, NVDA, ERIC, MU

See More DNDN News...

Sector

Healthcare

Industry

Drugs

Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks